Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.72% | 4.46% | 2.41% | 1.97% | 2.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.72% | 4.46% | 2.41% | 1.97% | 2.73% |
| Cost of Revenue | 6.90% | 7.79% | 8.18% | 6.04% | 6.45% |
| Gross Profit | 3.65% | 2.83% | -0.32% | 0.03% | 0.99% |
| SG&A Expenses | 16.78% | 8.66% | 11.22% | 13.16% | 5.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.55% | 8.01% | 9.15% | 9.09% | 5.54% |
| Operating Income | -15.46% | -7.31% | -17.18% | -18.12% | -5.96% |
| Income Before Tax | -29.85% | -26.11% | -38.03% | -45.17% | -29.46% |
| Income Tax Expenses | 6.72% | 1.31% | -32.30% | -66.96% | -48.99% |
| Earnings from Continuing Operations | -35.14% | -29.45% | -38.91% | -41.11% | -25.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 100.00% |
| Net Income | -35.14% | -29.45% | -38.91% | -41.07% | -25.18% |
| EBIT | -15.46% | -7.31% | -17.18% | -18.12% | -5.96% |
| EBITDA | -10.76% | -5.07% | -11.98% | -12.22% | -3.14% |
| EPS Basic | -35.34% | -29.62% | -39.02% | -41.27% | -25.46% |
| Normalized Basic EPS | -11.46% | -7.01% | -18.44% | -23.23% | -13.02% |
| EPS Diluted | -33.87% | -27.25% | -37.31% | -40.19% | -25.19% |
| Normalized Diluted EPS | -10.77% | -6.31% | -17.63% | -22.47% | -12.24% |
| Average Basic Shares Outstanding | 0.27% | 0.26% | 0.20% | 0.33% | 0.39% |
| Average Diluted Shares Outstanding | -0.48% | -0.41% | -0.76% | -0.67% | -0.61% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.55% | 0.42% | 0.64% | 0.70% | 0.34% |